Related Experiment Video
Updated: Jan 12, 2026

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Exercise improves high-fat diet-induced lipid metabolic and cardiac dysfunction via AMPK-PGC-1α/dLipin
Yuepeng Li1, Meng Ding1, Wenqing Huang1
1Key Laboratory of Physical Fitness and Exercise Rehabilitation of Hunan Province, Hunan Normal University, Changsha, China.
Abstract:
High-fat diet (HFD)-induced lipid metabolism abnormalities and cardiac dysfunction are important risk factors for cardiovascular disease. Although exercise can improve lipid metabolism abnormalities, its molecular mechanisms remain unclear. This study used Drosophila as a model to investigate the regulatory mechanisms of exercise on HFD-induced lipid metabolism abnormalities and cardiac dysfunction. Results showed that HFD caused lipid accumulation, impaired cardiac contractility, and arrhythmia in fly, accompanied by upregulation of dLipin expression and suppression of the AMPK-PGC-1α signaling pathway in cardiomyocytes. Exercise intervention activated the AMPK-PGC-1α axis to transcriptionally inhibit dLipin, thereby improving HFD-induced lipid metabolism abnormalities and cardiac dysfunction. Knockdown experiments confirmed that dLipin knockdown in cardiomyocytes protected against HFD-induced lipid metabolic abnormalities and cardiac dysfunction, while PGC-1α knockdown blocked the inhibitory effect of exercise on dLipin and its cardiac protective effects. This study reveals that exercise improves HFD-induced lipid metabolic abnormalities and cardiac dysfunction through the AMPK-PGC-1α/dLipin pathway, providing a new strategy for targeted treatment of obesity-related cardiovascular diseases.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Atherosclerosis III: Management

